Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer.
about
Novel tools for prostate cancer prognosis, diagnosis, and follow-upMolecular pathways and targets in prostate cancerAndrogen receptors beyond prostate cancer: an old marker as a new target.Neoadjuvant Treatment of High-Risk, Clinically Localized Prostate Cancer Prior to Radical Prostatectomy.DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.Prognostic role of genetic biomarkers in clinical progression of prostate cancer.Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy.
P2860
Q33625338-977BB131-82CD-483C-924E-F401E21A8573Q34365632-1D6F98F0-E746-4457-90B2-71C7C8211232Q34458538-859B3CB8-69EA-40A1-8BE5-D08A7079A516Q38770371-4860F975-2A66-4E9F-B141-A38B05272144Q38774228-DA2F8EF5-C1DD-486F-A050-61BFEA8ADC26Q38976733-903B728A-1138-484D-B919-1D01544DB457Q39044222-45A58CF7-CAFB-4BE8-B757-F5DC74AF72D2Q51549809-816FA656-A8DD-474C-BA5F-8BE0F33F9B04
P2860
Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genetic profiling to determine ...... isk localized prostate cancer.
@ast
Genetic profiling to determine ...... isk localized prostate cancer.
@en
type
label
Genetic profiling to determine ...... isk localized prostate cancer.
@ast
Genetic profiling to determine ...... isk localized prostate cancer.
@en
prefLabel
Genetic profiling to determine ...... isk localized prostate cancer.
@ast
Genetic profiling to determine ...... isk localized prostate cancer.
@en
P2093
P2860
P1476
Genetic profiling to determine ...... risk localized prostate cancer
@en
P2093
Andrea Warrick
Carol Beadling
Celestia S Higano
Christine M Barnett
Christopher L Corless
David Qian
Dylan Nelson
George V Thomas
Mark Garzotto
P2860
P304
P356
10.1158/1078-0432.CCR-13-1775
P407
P577
2013-12-18T00:00:00Z